LEADER 01109oam 2200349zu 450 001 9910144702303321 005 20210807003037.0 010 $a3-527-62086-9 035 $a(CKB)1000000000687481 035 $a(SSID)ssj0000388113 035 $a(PQKBManifestationID)12154469 035 $a(PQKBTitleCode)TC0000388113 035 $a(PQKBWorkID)10430969 035 $a(PQKB)11605829 035 $a(EXLCZ)991000000000687481 100 $a20160829d1999 uy 101 0 $aeng 181 $ctxt 182 $cc 183 $acr 200 10$aBiotechnology, Recombinant Proteins, Monoclonal Antibodies, and Therapeutic Genes. Vol. 5 210 31$a[Place of publication not identified]$cWiley VCH Imprint$d1999 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a3-527-28315-3 700 $aMountain$b A$0991016 702 $aSchomburg$b Dietmar 702 $aNey$b U. M 801 0$bPQKB 906 $aBOOK 912 $a9910144702303321 996 $aBiotechnology, Recombinant Proteins, Monoclonal Antibodies, and Therapeutic Genes. Vol. 5$92267840 997 $aUNINA